根除幽门螺旋杆菌前后患者GerdQ评分变化情况分析
Analysis of Changes of GerdQ Score before and after Eradication of H. pylori
DOI: 10.12677/ACM.2022.12111517, PDF,   
作者: 张绍华, 汤云鹤:青岛大学,山东 青岛;毛 涛*:青岛大学附属医院消化内科,山东 青岛
关键词: 幽门螺旋杆菌胃食管反流病GerdQ评分Helicobacter Pylori Gastroesophageal Reflux Disease GerdQ Score
摘要: 目的:本研究旨在探究根除幽门螺旋杆菌(Hp)前后患者GerdQ评分变化情况,并探讨影响评分改变的危险因素。方法:本研究纳入162例于青岛大学附属医院成功根除Hp的患者,在其治疗前及治疗1月以上复查时分别检测其GerdQ评分。同时,通过门诊及随访收集患者既往史及个人史,分析性别、年龄、既往病史等对于GerdQ评分变化的影响情况。结果:患者成功根除Hp后其GerdQ评分较前明显升高(p = 0.005),且女性(p = 0.031)与既往胃食管反流病(Gerd)病史(p = 0.011)是根除Hp后GerdQ评分升高的独立危险因素,两者与评分升高呈正相关。结论:根除Hp会导致GerdQ评分升高,女性及既往Gerd病史是其独立危险因素。
Abstract: Objective: The aim of this study was to investigate the changes in GerdQ scores of patients before and after eradication of Helicobacter pylori (Hp) and to investigate the risk factors affecting the changes in scores. Methods: This study included 162 patients who were successfully eradicated Hp from the Affiliated Hospital of Qingdao University, and their GerdQ scores were measured before treatment and at the follow-up examination more than 1 month after treatment. At the same time, the past and personal histories of the patients were collected. The influence of gender, age and past medical history on the change of GerdQ score was analyzed. Results: GerdQ scores were significantly higher after successful Hp eradication (p = 0.005), and female (p = 0.031) and previous history of gastroesophageal reflux disease (GERD) (p = 0.011) were independent risk factors for higher GerdQ scores after Hp eradication, and both were positively associated with higher scores. Conclusion: Hp eradication leads to the elevation of GerdQ scores, while women and previous history of Gerd are independent risk factors for this.
文章引用:张绍华, 汤云鹤, 毛涛. 根除幽门螺旋杆菌前后患者GerdQ评分变化情况分析[J]. 临床医学进展, 2022, 12(11): 10539-10544. https://doi.org/10.12677/ACM.2022.12111517

参考文献

[1] El-Serag, H., Sweet, S., Winchester, C. and Dent, J. (2014) Update on the Epidemiology of Gastro-Oesophageal Reflux Disease: A Systematic Review. Gut, 63, 871-880. [Google Scholar] [CrossRef] [PubMed]
[2] Herregods, T., Bredenoord, A. and Smout, A. (2015) Pathophysiology of Gastroesophageal Reflux Disease: New Understanding in a New Era. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society, 27, 1202-1213. [Google Scholar] [CrossRef] [PubMed]
[3] 张玲, 邹多武. 胃食管反流病的流行病学及危险因素[J]. 临床荟萃, 2017, 32(1): 1-4.
[4] He, J., Ma, X., Zhao, Y., et al. (2010) A Population-Based Survey of the Epidemiol-ogy of Symptom-Defined Gastroesophageal Reflux Disease: The Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterology, 10, Article No. 94. [Google Scholar] [CrossRef
[5] Fischbach, W. and Malfertheiner, P. (2018) Helicobacter pylori Infection. Deutsches Arzteblatt International, 115, 429-436. [Google Scholar] [CrossRef] [PubMed]
[6] Sugimoto, M., Uotani, T., Ichikawa, H. andoh, A. and Furuta, T. (2016) Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan. Digestion, 93, 24-31. [Google Scholar] [CrossRef] [PubMed]
[7] Fujiwara, Y., Higuchi, K., Shiba, M., et al. (2003) Association between Gastroesophageal Flap Valve, Reflux Esophagitis, Barrett’s Epithelium, and Atrophic Gastritis Assessed by Endoscopy in Japanese Patients. Journal of Gastroenterology, 38, 533-539. [Google Scholar] [CrossRef] [PubMed]
[8] Ghoshal, U. and Chourasia, D. (2010) Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship? Journal of Neurogastroenterology and Motility, 16, 243-250. [Google Scholar] [CrossRef] [PubMed]
[9] Lee, Y.C., Chiang, T.H., Chou, C.K., et al. (2016) Asso-ciation between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-Analysis. Gastroenterology, 150, 1113-1124.e5. [Google Scholar] [CrossRef] [PubMed]
[10] Lahner, E., Carabotti, M. and Annibale, B. (2018) Helicobacter pylori Treatment of Infection in Atrophic Gastritis. World Journal of Gastroenterology, 24, 2373-2380. [Google Scholar] [CrossRef] [PubMed]
[11] 玉素甫•买买提, 赛甫丁•艾比布拉, 麦麦提艾力•麦麦提明, 克力木•阿不都热依木. GerdQ评分量表在初步诊断食管反流病中的应用[J]. 中华胃食管反流病电子杂志, 2017, 4(1): 27-30.
[12] Norder Grusell, E., Mjörnheim, A., Finizia, C., et al. (2018) The Diagnostic Value of GerdQ in Sub-jects with Atypical Symptoms of Gastro-Esophageal Reflux Disease. Scandinavian Journal of Gastroenterology, 53, 1165-1170. [Google Scholar] [CrossRef] [PubMed]
[13] Fass, R., Boeckxstaens, G., El-Serag, H., Rosen, R., Sifrim, D. and Vaezi, M. (2021) Gastro-Oesophageal Reflux Disease. Nature Reviews Disease Primers, 7, Article No. 55. [Google Scholar] [CrossRef] [PubMed]
[14] 王玲, 罗伟, 张雪莲. 胃食管反流性咽喉疾病与幽门螺旋杆菌感染相关性研究[J]. 北华大学学报(自然科学版), 2018, 19(6): 792-795.
[15] Vakil, N., van Zanten, S., Kahrilas, P., Dent, J. and Jones, R. (2006) The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. The American Journal of Gastroenterology, 101, 1900-1920. [Google Scholar] [CrossRef] [PubMed]
[16] Yucel, O. (2019) Interactions between Helicobacter pylori and Gastroesophageal Reflux Disease. Esophagus: Official Journal of the Japan Esophageal Society, 16, 52-62. [Google Scholar] [CrossRef] [PubMed]
[17] 华启洋, 吴同利, 刘永艳, 孙凤芹, 姚燕. 幽门螺杆菌在胃食管反流病发病中的作用[J]. 医学信息, 2019, 32(20): 103-104+7.
[18] Savoldi, A., Carrara, E., Graham, D., Conti, M. and Tacconelli, E. (2018) Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Me-ta-Analysis in World Health Organization Regions. Gastroenterology, 155, 1372-1382.e17. [Google Scholar] [CrossRef] [PubMed]
[19] de Brito, B., da Silva, F., Soares, A., et al. (2019) Helicobacter pylori Pathogenesis and Clinical Management of Gastric Infection. World Journal of Gastroenterology, 25, 5578-5589. [Google Scholar] [CrossRef] [PubMed]
[20] Beales, I.L. and Calam, J. (1998) Interleukin 1 Beta and Tumour Necrosis Factor Alpha Inhibit Acid Secretion in Cultured Rabbit Parietal Cells by Multiple Pathways. Gut, 42, 227-234. [Google Scholar] [CrossRef] [PubMed]
[21] Hojo, M., Ueda, K., Takeda, T., et al. (2021) The Relationship between Helicobacter pylori Infection and Reflux Esophagitis and the Long-Term Effects of Eradication of Helicobacter pylori on Reflux Esophagitis. Therapeutic Advances in Gastroenterology, 14, 1-10. [Google Scholar] [CrossRef] [PubMed]
[22] Hamada, H., Haruma, K., Mihara, M., et al. (2000) High Inci-dence of Reflux Oesophagitis after Eradication Therapy for Helicobacter pylori: Impacts of Hiatal Hernia and Corpus Gastritis. Alimentary Pharmacology & Therapeutics, 14, 729-735. [Google Scholar] [CrossRef] [PubMed]
[23] Iijima, K., Koike, T. and Shimosegawa, T. (2015) Reflux Esophagitis Triggered after Helicobacter pylori Eradication: A Noteworthy Demerit of Eradication Therapy among the Japanese? Frontiers in Microbiology, 6, Article No. 566. [Google Scholar] [CrossRef] [PubMed]
[24] Minatsuki, C., Yamamichi, N., Shimamoto, T., et al. (2013) Back-ground Factors of Reflux Esophagitis and Non-Erosive Reflux Disease: A Cross-Sectional Study of 10,837 Subjects in Japan. PLOS ONE, 8, e69891. [Google Scholar] [CrossRef] [PubMed]
[25] 中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663.
[26] Surdea-Blaga, T., Negrutiu, D., Palage, M. and Dumitrascu, D. (2019) Food and Gastroesophageal Reflux Disease. Current Medicinal Chemistry, 26, 3497-3511. [Google Scholar] [CrossRef] [PubMed]
[27] 周琦, 高照勤, 唐英. 研究与饮食习惯及生活方式相关的胃食管反流病的危险因素[J]. 中华胃食管反流病电子杂志, 2015, 2(4): 252-253.